vaccines

Anna Blakney, an RNA bioengineer and TikTok science communicator, studies how self-amplifying RNA improves RNA vaccines and therapeutics.

Conserved across plants and animals, RNAi is a powerful mechanism with tremendous therapeutic potential.

LIVE April 19th, 2022 at 11:30 AM
Biologics targeting coronavirus and variants of interest emerge as the latest therapeutic strategy for treating COVID-19.

As reports of disrupted menstrual cycles after COVID-19 vaccinations rose, researchers investigated the connection. Their reports revealed that while vaccine-associated menstrual changes may be small and temporary, knowledge of these potential side effects is vital for public trust.

LIVE March 22nd, 2022 at 2:30 PM
Discover how researchers are correcting disease mutations with CRISPR genome editing.

The history of antibody research has led to modern immunotherapy treatments for infectious diseases.

Small antibodies called nanobodies produced in camels, llamas, and alpacas might help stop the spread of COVID-19, but can they stand up against the competition?

The recent COVID-19 mRNA vaccines represent a new wave of vaccines based on mRNA technology.

A GLP-grade non-replicative Leishmania major parasite protects hamsters from lethal leishmaniasis infection, setting the stage for human clinical trials and the first potential vaccine for leishmaniasis.

LIVE August 30th, 2021 at 1:30 PM ET

In this webinar, researchers will discuss new bacteriophage approaches to fight antibiotic-resistant microbes.